Jiangsu Bioperfectus Technology Co. Ltd (Bioperfectus) was founded in 2010 at China Medical City (CMC), Taizhou, Jiangsu province. In 16 October and 7 November 2019, the company’s IPO application was approved by Shanghai Stock Exchange and China Securities Regulatory Commission, respectively. Since 5 December 2019, Bioperfectus became a Sci-Tech innovation board (STAR market) listed company. As a leading In Vitro Diagnostic (IVD) product supplier in China, Bioperfectus specializes in developing, manufacturing and selling IVD reagents, diagnostic instruments as well as providing IVD diagnostic services. Currently, Bioperfectus has realized integrated business model by combining reagent, instrument and service.